Scarica l'app Stockscreener
18.64
4.26%
-0.83
Dopo l'orario di chiusura:
18.64
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$19.47
Aprire:
$19.37
Volume 24 ore:
866.45K
Relative Volume:
1.14
Capitalizzazione di mercato:
$1.52B
Reddito:
$305.00K
Utile/perdita netta:
$-328.98M
Rapporto P/E:
-4.8668
EPS:
-3.83
Flusso di cassa netto:
$-309.60M
1 W Prestazione:
+1.08%
1M Prestazione:
+10.56%
6M Prestazione:
+22.43%
1 anno Prestazione:
+25.61%
Intervallo 1D:
$18.12
$19.67
Intervallo di 1 settimana:
$18.00
$20.05
Portata 52W:
$9.90
$27.20
Viridian Therapeutics Inc Stock (VRDN) Company Profile
Nome
Viridian Therapeutics Inc
Settore
Industria
Telefono
617.272.4600
Indirizzo
221 CRESCENT STREET, WALTHAM
Confronta VRDN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VRDN
Viridian Therapeutics Inc
|
18.64 | 1.56B | 305.00K | -328.98M | -309.60M | -3.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Ripresa | Jefferies | Buy |
| 2024-12-19 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-11-25 | Iniziato | TD Cowen | Buy |
| 2024-09-11 | Reiterato | Needham | Buy |
| 2024-06-11 | Iniziato | Wolfe Research | Outperform |
| 2024-06-06 | Iniziato | Goldman | Buy |
| 2024-05-09 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2024-05-09 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2023-06-14 | Iniziato | BTIG Research | Buy |
| 2023-06-14 | Ripresa | Credit Suisse | Outperform |
| 2023-05-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-04-17 | Iniziato | Wells Fargo | Overweight |
| 2023-03-30 | Iniziato | Stifel | Buy |
| 2022-12-19 | Iniziato | Cowen | Outperform |
| 2022-12-19 | Iniziato | Needham | Buy |
| 2022-12-16 | Iniziato | Credit Suisse | Outperform |
| 2022-12-01 | Iniziato | H.C. Wainwright | Buy |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2021-11-18 | Iniziato | SVB Leerink | Outperform |
| 2021-10-12 | Iniziato | Evercore ISI | Outperform |
| 2021-01-25 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Viridian Therapeutics Inc Borsa (VRDN) Ultime notizie
Viridian Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Can Viridian Therapeutics Inc. lead its sector in growthTrade Performance Summary & AI Driven Price Forecasts - khodrobank.com
Can Viridian Therapeutics Inc. reach all time highs this yearWeekly Trading Summary & High Accuracy Swing Entry Alerts - khodrobank.com
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Measuring Viridian Therapeutics Inc.’s beta against major indicesM&A Rumor & Daily Stock Trend Reports - Newser
Published on: 2025-09-03 09:36:11 - Newser
Pattern recognition hints at Viridian Therapeutics Inc. upsideQuarterly Portfolio Summary & Community Consensus Trade Alerts - Newser
Candlestick signals on Viridian Therapeutics Inc. stock today2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - Newser
Is a relief rally coming for Viridian Therapeutics Inc. holdersWeekly Profit Analysis & AI Enhanced Trading Alerts - Newser
Viridian Therapeutics Inc. stock momentum explainedJuly 2025 Price Swings & Accurate Buy Signal Alerts - Newser
Will Viridian Therapeutics Inc. bounce back from current supportShort Setup & Long Hold Capital Preservation Plans - Newser
Will breakout in Viridian Therapeutics Inc. lead to full recoveryMarket Risk Summary & Weekly Momentum Stock Picks - Newser
Will Viridian Therapeutics Inc. rebound enough to break evenJuly 2025 Price Swings & Capital Protection Trading Alerts - Newser
How to use Fibonacci retracement on Viridian Therapeutics Inc.Weekly Investment Recap & Smart Investment Allocation Tips - Newser
Technical analysis overview for Viridian Therapeutics Inc. stockJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - Newser
Is Viridian Therapeutics Inc. trading at a discountJuly 2025 Weekly Recap & Daily Entry Point Alerts - khodrobank.com
Leading vs lagging indicators on Viridian Therapeutics Inc. performanceQuarterly Investment Review & Weekly High Potential Alerts - Newser
Does Viridian Therapeutics Inc. have a competitive edgeJuly 2025 Weekly Recap & Community Consensus Trade Alerts - khodrobank.com
Will Viridian Therapeutics Inc. see short term momentum2025 Buyback Activity & Long Hold Capital Preservation Tips - Newser
Published on: 2025-09-02 12:18:28 - Newser
Is Viridian Therapeutics Inc. a turnaround storyJuly 2025 Snapshot & Verified Entry Point Signals - khodrobank.com
Viridian Therapeutics Inc. stock trend outlook and recovery pathEarnings Overview Report & Real-Time Buy Zone Alerts - Newser
Is Viridian Therapeutics Inc. a good ESG investmentJuly 2025 Drop Watch & Safe Investment Capital Preservation Plans - khodrobank.com
Published on: 2025-09-01 22:08:54 - Newser
Is Viridian Therapeutics Inc. stock a value trap2025 Risk Factors & Verified Momentum Watchlists - khodrobank.com
Price Consolidation Hints at Upcoming Move in Viridian Therapeutics Inc.2025 Year in Review & Safe Capital Growth Plans - sundaytimes.kr
Applying big data sentiment scoring on Viridian Therapeutics Inc.2025 Winners & Losers & Safe Entry Momentum Tips - Newser
Will Viridian Therapeutics Inc. stock recover after recent dropJuly 2025 Sentiment & Stock Market Timing Techniques - Newser
Combining price and volume data for Viridian Therapeutics Inc.2025 Price Action Summary & High Return Trade Guides - Newser
Published on: 2025-08-31 12:51:18 - Newser
Identifying reversal signals in Viridian Therapeutics Inc.July 2025 Closing Moves & Momentum Based Trading Signals - Newser
Detecting price anomalies in Viridian Therapeutics Inc. with AIPortfolio Profit Report & Fast Gain Swing Alerts - Newser
Analyzing Viridian Therapeutics Inc. with multi timeframe charts2025 Big Picture & Precise Entry and Exit Recommendations - Newser
What momentum shifts mean for Viridian Therapeutics Inc.2025 Bull vs Bear & High Return Trade Opportunity Guides - Newser
Viridian Therapeutics Inc Azioni (VRDN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Viridian Therapeutics Inc Azioni (VRDN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC | Director |
Jun 09 '25 |
Option Exercise |
7.80 |
1,600 |
12,480 |
3,447,413 |
| Beetham Thomas W. | Chief Operating Officer |
Sep 27 '24 |
Buy |
23.41 |
5,000 |
117,050 |
6,000 |
| Mahoney Stephen F. | President and CEO |
Sep 27 '24 |
Buy |
23.33 |
21,400 |
499,262 |
21,400 |
| Fairmount Funds Management LLC | Director |
Sep 13 '24 |
Buy |
18.75 |
1,600,000 |
30,000,000 |
3,445,813 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):